Cognitive and behavioral changes in Huntington disease before diagnosis

Handbook of Clinical Neurology

Volumn 144, Issue , 2017, Pages 69-91

  Paulsen, Jane S ^a   Miller, Amanda C ^a   Hayes, Terry ^a   Shaw, Emily ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

behavioral; cognition; diagnosis; Huntington disease; neuropsychology; personality; preclinical Huntington disease; premanifest Huntington disease; presymptomatic Huntington disease; prevention; preventive; prodromal Huntington disease; psychiatric; staging Huntington disease

Indexed keywords

COGNITION; DISEASE EXACERBATION; GENETICS; HUMAN; HUNTINGTON CHOREA; NEUROPSYCHOLOGICAL TEST; PRODROMAL SYMPTOM; PSYCHOLOGY;

COGNITION; DISEASE PROGRESSION; HUMANS; HUNTINGTON DISEASE; NEUROPSYCHOLOGICAL TESTS; PRODROMAL SYMPTOMS;

EID: 85044237189     PISSN: 00729752     EISSN: 22124152     Source Type: Book Series    
DOI: 10.1016/B978-0-12-801893-4.00006-7     Document Type: Chapter

References (148)

1. A'Campo, L.E., Spliethoff-Kamminga, N.G., Roos, R.A., The Patient Education Program for Huntington's Disease (PEP-HD). J Huntingtons Dis 1 (2012), 47–56.
2. Alexander, G.E., DeLong, M.R., Strick, P.L., Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9 (1986), 357–381.
3. Anderson, K.E., Gehl, C.R., Marder, K.S., et al. Comorbidities of obsessive and compulsive symptoms in Huntington's disease. J Nerv Ment Dis 198 (2010), 334–338.
4. Aylward, E.H., Liu, D., Nopoulos, P.C., et al. Striatal volume contributes to the prediction of onset of Huntington disease in incident cases. Biol Psychiatry 71 (2012), 822–828.
5. Bacon Moore, A.S., Paulsen, J.S., Murphy, C., A test of odor fluency in patients with Alzheimer's and Huntington's disease. J Clin Exp Neuropsychol 21 (1999), 341–351.
6. Barresi, M., Ciurleo, R., Giacoppo, S., et al. Evaluation of olfactory dysfunction in neurodegenerative diseases. J Neurol Sci 323 (2012), 16–24.
7. Begeti, F., Schwab, L.C., Mason, S.L., et al. Hippocampal dysfunction defines disease onset in Huntington's disease. J Neurol Neurosurg Psychiatry 87 (2016), 975–981.
8. Beglinger, L.J., Paulsen, J.S., Watson, D.B., et al. Obsessive and compulsive symptoms in prediagnosed Huntington's disease. J Clin Psychiatry 69 (2008), 1758–1765.
9. Beglinger, L.J., Duff, K., Allison, J., et al. Cognitive change in patients with Huntington disease on the repeatable battery for the assessment of neuropsychological status. J Clin Exp Neuropsychol 32 (2010), 573–578.
10. Beglinger, L.J., O'Rourke, J.J., Wang, C., et al. Earliest functional declines in Huntington disease. Psychiatry Res 178 (2010), 414–418.
11. Berrios, G.E., Wagle, A.C., Markova, I.S., et al. Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers. Psychiatry Res 102 (2001), 217–225.
12. Beste, C., Stock, A.K., Ness, V., et al. A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data. Sci Rep, 3, 2013, 1797.
13. Beste, C., Stock, A.K., Ness, V., et al. Evidence for divergent effects of neurodegeneration in Huntington's disease on attentional selection and neural plasticity: implications for excitotoxicity. Brain Struct Funct 220 (2015), 1437–1447.
14. Blekher, T.M., Yee, R.D., Kirkwood, S.C., et al. Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease. Vision Res 44 (2004), 2729–2736.
15. Blekher, T., Johnson, S.A., Marshall, J., et al. Saccades in presymptomatic and early stages of Huntington disease. Neurology 67 (2006), 394–399.
16. Bonner-Jackson, A., Long, J.D., Westervelt, H., et al. Cognitive reserve and brain reserve in prodromal Huntington's disease. J Int Neuropsychol Soc 19 (2013), 739–750.
17. Bouwens, J.A., van Duijn, E., van der Mast, R.C., et al. Irritability in a prospective cohort of Huntington's disease mutation carriers. J Neuropsychiatry Clin Neurosci 27 (2015), 206–212.
18. Brooks, S.P., Dunnett, S.B., Cognitive deficits in animal models of basal ganglia disorders. Brain Res Bull 92 (2013), 29–40.
19. Calder, A.J., Keane, J., Young, A.W., et al. The relation between anger and different forms of disgust: implications for emotion recognition impairments in Huntington's disease. Neuropsychologia 48 (2010), 2719–2729.
20. Callaghan, J., Stopford, C., Arran, N., et al. Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington's disease (PBA-s) in the TRACK-HD and REGISTRY studies. J Neuropsychiatry Clin Neurosci 27 (2015), 59–64.
21. Carrasco, M.C., Guillem, M.J., Redolat, R., Estimation of short temporal intervals in Alzheimer's disease. Exp Aging Res 26 (2000), 139–151.
22. Chisholm, L.Z., Flavin, K.T., Paulsen, J.S., et al. Psychological well-being in persons affected by Huntington's disease: a comparison of at-risk, prodromal, and symptomatic groups. J Health Psychol 18 (2013), 408–418.
23. Cipriani, G., Lucetti, C., Danti, S., et al. Apathy and dementia. Nosology, assessment and management. J Nerv Ment Dis 202 (2014), 718–724.
24. Craufurd, D., Thompson, J.C., Snowden, J.S., Behavioral changes in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol 14 (2001), 219–226.
25. Dale, M., van Duijn, E., Anxiety in Huntington's disease. J Neuropsychiatry Clin Neurosci 27 (2015), 262–271.
26. Dale, M., Maltby, J., Shimozaki, S., et al. Disease stage, but not sex, predicts depression and psychological distress in Huntington's disease: a European population study. J Psychosom Res 80 (2016), 17–22.
27. Davalos, D.B., Kisley, M.A., Freedman, R., Behavioral and electrophysiological indices of temporal processing dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 17 (2005), 517–525.
28. Deckel, A.W., Morrison, D., Evidence of a neurologically based “denial of illness” in patients with Huntington's disease. Arch Clin Neuropsychol 11 (1996), 295–302.
29. Dorsey, E.R., Beck, C.A., Darwin, K., et al. Natural history of Huntington disease. JAMA Neurol 70 (2013), 1520–1530.
30. Downing, N., Smith, M.M., Beglinger, L.J., et al. Perceived stress in prodromal Huntington disease. Psychol Health 27 (2012), 196–209.
31. Duff, K., Paulsen, J., Mills, J., et al. Mild cognitive impairment in prediagnosed Huntington disease. Neurology 75 (2010), 500–507.
32. Duff, K., Paulsen, J.S., Beglinger, L.J., et al. “Frontal” behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci 22 (2010), 196–207.
33. Dumas, E.M., van den Bogaard, S.J., Middelkoop, H.A., et al. A review of cognition in Huntington's disease. Front Biosci (Schol Ed) 5 (2013), 1–18.
34. Eddy, C.M., Rickards, H.E., Theory of mind can be impaired prior to motor onset in Huntington's disease. Neuropsychology 29 (2015), 792–798.
35. Epping, E.A., Paulsen, J.S., Depression in the early stages of Huntington disease. Neurodegener Dis Manag 1 (2011), 407–414.
36. Epping, E.A., Mills, J.A., Beglinger, L.J., et al. Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study. J Psychiatr Res 47 (2013), 1423–1431.
37. Epping, E.A., Kim, J.I., Craufurd, D., et al. Longitudinal psychiatric symptoms in prodromal Huntington's disease: a decade of data. Am J Psychiatry 173 (2016), 184–192.
38. Erwin, C., Williams, J.K., Juhl, A.R., et al. Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study. Am J Med Genet B Neuropsychiatr Genet 153B (2010), 1081–1093.
39. Farias, S.T., Mungas, D., Reed, B.R., et al. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology 22:4 (2008), 531–544.
40. Ferris, C.F., Kulkarni, P., Toddes, S., et al. Studies on the Q175 Knock-in model of Huntington's disease using functional imaging in awake mice: evidence of olfactory dysfunction. Front Neurol, 5, 2014, 94.
41. Fibbe, L.A., Cath, D.C., van den Heuvel, O.A., et al. Relationship between movement disorders and obsessive-compulsive disorder: beyond the obsessive-compulsive-tic phenotype. A systematic review J Neurol Neurosurg Psychiatry 83 (2012), 646–654.
42. Fiedorowicz, J.G., Mills, J.A., Ruggle, A., et al. Suicidal behavior in prodromal Huntington disease. Neurodegener Dis 8 (2011), 483–490.
43. Filoteo, J.V., Delis, D.C., Roman, M.J., et al. Visual attention and perception in patients with Huntington's disease: comparisons with other subcortical and cortical dementias. J Clin Exp Neuropsychol 17 (1995), 654–667.
44. Fisher, C.A., Sewell, K., Brown, A., et al. Aggression in Huntington's disease: a systematic review of rates of aggression and treatment methods. J Huntingtons Dis 3 (2014), 319–332.
45. Food and Drug Administration, Clinical outcome assessment qualification program. Available online at, 2016 http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopmentToolsQualificationProgram/ucm284077.htm (accessed May 5 2016).
46. Halpin, M., Accounts of suicidality in the Huntington disease community. Omega (Westport) 65 (2012), 317–334.
47. Hamilton, J.M., Murphy, C., Paulsen, J.S., Odor detection, learning, and memory in Huntington's disease. J Int Neuropsychol Soc 5 (1999), 609–615.
48. Hamilton, J.M., Salmon, D.P., Corey-Bloom, J., et al. Behavioural abnormalities contribute to functional decline in Huntington's disease. J Neurol Neurosurg Psychiatry 74 (2003), 120–122.
49. Harrington, D.L., Smith, M.M., Zhang, Y., et al. Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 83 (2012), 612–619.
50. Harrington, D.L., Liu, D., Smith, M.M., et al. Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease. Brain Behav 4 (2014), 29–40.
51. Harrington, D.L., Rubinov, M., Durgerian, S., et al. Network topology and functional connectivity disturbances precede the onset of Huntington's disease. Brain 138 (2015), 2332–2346.
52. Hart, E.P., Dumas, E.M., van Zwet, E.W., et al. Longitudinal pilot-study of sustained attention to response task and P300 in manifest and pre-manifest Huntington's disease. J Neuropsychol 9 (2015), 10–20.
53. Hinton, S.C., Paulsen, J.S., Hoffmann, R.G., et al. Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches. J Int Neuropsychol Soc 13 (2007), 539–543.
54. Hoth, K.F., Paulsen, J.S., Moser, D.J., et al. Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol 29 (2007), 365–376.
55. Hubers, A.A., Reedeker, N., Giltay, E.J., et al. Suicidality in Huntington's disease. J Affect Disord 136 (2012), 550–557.
56. Huntington, G., On chorea. The Medical and Surgical Reporter: A Weekly Journal 26 (1872), 317–321.
57. Huntington Study Group, Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 11 (1996), 136–142.
58. Johnson, S.A., Stout, J.C., Solomon, A.C., et al. Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease. Brain 130 (2007), 1732–1744.
59. Julien, C.L., Thompson, J.C., Wild, S., et al. Psychiatric disorders in preclinical Huntington's disease. J Neurol Neurosurg Psychiatry 78 (2007), 939–943.
60. Kim, J.I., Long, J.D., Mills, J.A., et al. Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease. Neuropsychology 29 (2015), 949–960.
61. Kirkwood, S.C., Siemers, E., Stout, J.C., et al. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol 56 (1999), 563–568.
62. Kirkwood, S.C., Siemers, E., Viken, R., et al. Longitudinal personality changes among presymptomatic Huntington disease gene carriers. Neuropsychiatry Neuropsychol Behav Neurol 15 (2002), 192–197.
63. Kloppel, S., Gregory, S., Scheller, E., et al. Compensation in preclinical Huntington's disease: evidence from the Track-On HD study. EBioMedicine 2 (2015), 1420–1429.
64. Krishnamoorthy, A., Craufurd, D., Treatment of apathy in Huntington's disease and other movement disorders. Curr Treat Options Neurol 13 (2011), 508–519.
65. Langbehn, D.R., Brinkman, R.R., Falush, D., et al. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 65 (2004), 267–277.
66. Langbehn, D.R., Hayden, M.R., Paulsen, J.S., et al. CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet 153B (2010), 397–408.
67. Lawrence, A.D., Hodges, J.R., Rosser, A.E., et al. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 121 (1998), 1329–1341.
68. Levy, M.L., Cummings, J.L., Fairbanks, L.A., et al. Apathy is not depression. J Neuropsychiatry Clin Neurosci 10 (1998), 314–319.
69. Lezak, M.D., Neuropsychological assessment. 2012, Oxford University Press, Oxford.
70. Liou, S., The behavioral symptoms of Huntington's disease. Available online at: 2010 http://web.stanford.edu/group/hopes/cgi-bin/hopes_test/the-behavioral-symptoms-of-huntingtons-disease/ (accessed April 1 2016).
71. Long, J.D., Paulsen, J.S., Marder, K., et al. Tracking motor impairments in the progression of Huntington's disease. Mov Disord 29 (2014), 311–319.
72. Long, J.D., Paulsen, J.S., PREDICT-HD Investigators and Coordinators of the Huntington Study Group. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD. Mov Disord 30 (2015), 1664–1672.
73. Maroof, D.A., Gross, A.L., Brandt, J., Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease. J Clin Exp Neuropsychol 33 (2011), 901–909.
74. Marshall, J., White, K., Weaver, M., et al. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers. Arch Neurol 64 (2007), 116–121.
75. Martinez-Horta, S., Perez-Perez, J., van Duijn, E., et al. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease. Parkinsonism Relat Disord 25 (2016), 58–64.
76. Mason, S., Barker, R.A., Rating apathy in Huntington's disease: patients and companions agree. J Huntingtons Dis 4 (2015), 49–59.
77. Mason, S.L., Zhang, J., Begeti, F., et al. The role of the amygdala during emotional processing in Huntington's disease: from pre-manifest to late stage disease. Neuropsychologia 70 (2015), 80–89.
78. McCusker, E., Loy, C.T., The many facets of unawareness in Huntington disease. Tremor Other Hyperkinet Mov (N Y), 4, 2014, 257.
79. McCusker, E.A., Gunn, D.G., Epping, E.A., et al. Unawareness of motor phenoconversion in Huntington disease. Neurology 81 (2013), 1141–1147.
80. Miller, A.C., Kim, J.I., Paulsen, J.S., Frontal systems behaviors in Huntingtons: participant versus companion ratings. Presented at Huntington Study Group Annual Meeting. 2014, Minneapolis, MN.
81. Montoya, A., Price, B.H., Menear, M., et al. Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci 31 (2006), 21–29.
82. Nehl, C., Ready, R.E., Hamilton, J., et al. Effects of depression on working memory in presymptomatic Huntington's disease. J Neuropsychiatry Clin Neurosci 13 (2001), 342–346.
83. Nehl, C., Paulsen, J.S., Huntington Study Group. Cognitive and psychiatric aspects of Huntington disease contribute to functional capacity. J Nerv Ment Dis 192 (2004), 72–74.
84. Nordin, S., Paulsen, J.S., Murphy, C., Sensory- and memory-mediated olfactory dysfunction in Huntington's disease. J Int Neuropsychol Soc 1 (1995), 281–290.
85. O'Rourke, J.J., Beglinger, L.J., Smith, M.M., et al. The Trail Making Test in prodromal Huntington disease: contributions of disease progression to test performance. J Clin Exp Neuropsychol 33 (2011), 567–579.
86. Paulsen, J.S., Early detection of Huntington disease. Future Neurol, 5, 2010.
87. Paulsen, J.S., Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep 11 (2011), 474–483.
88. Paulsen, J.S., Long, J.D., Onset of Huntington's disease: can it be purely cognitive?. Mov Disord 29 (2014), 1342–1350.
89. Paulsen, J.S., Ready, R.E., Hamilton, J.M., et al. Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry 71 (2001), 310–314.
90. Paulsen, J.S., Zhao, H., Stout, J.C., et al. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 57 (2001), 658–662.
91. Paulsen, J.S., Zimbelman, J.L., Hinton, S.C., et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. AJNR Am J Neuroradiol 25 (2004), 1715–1721.
92. Paulsen, J.S., Hoth, K.F., Nehl, C., et al. Critical periods of suicide risk in Huntington's disease. Am J Psychiatry 162 (2005), 725–731.
93. Paulsen, J.S., Hayden, M., Stout, J.C., et al. Preparing for preventive clinical trials: the Predict-HD study. Arch Neurol 63 (2006), 883–890.
94. Paulsen, J.S., Langbehn, D.R., Stout, J.C., et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 79 (2008), 874–880.
95. Paulsen, J.S., Nopoulos, P.C., Aylward, E., et al. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 82 (2010), 201–207.
96. Paulsen, J.S., Wang, C., Duff, K., et al. Challenges assessing clinical endpoints in early Huntington disease. Mov Disord 25 (2010), 2595–2603.
97. Paulsen, J.S., et al. Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep. 11:5 (2011), 474–483.
98. Paulsen, J.S., Nance, M., Kim, J.I., et al. A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Prog Neurobiol 110 (2013), 2–28.
99. Paulsen, J.S., Smith, M.M., Long, J.D., et al. Cognitive decline in prodromal Huntington disease: implications for clinical trials. J Neurol Neurosurg Psychiatry 84 (2013), 1233–1239.
100. Paulsen, J.S., Long, J.D., Johnson, H.J., et al. Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study. Front Aging Neurosci, 6, 2014, 78.
101. Paulsen, J.S., Long, J.D., Ross, C.A., et al. Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study. Lancet Neurol 13 (2014), 1193–1201.
102. Paulsen, D.J., Hallquist, M.N., Geier, C.F., et al. Effects of incentives, age, and behavior on brain activation during inhibitory control: a longitudinal fMRI study. Dev Cogn Neurosci 11 (2015), 105–115.
103. Penney, J.B. Jr., Vonsattel, J.P., MacDonald, M.E., et al. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 41 (1997), 689–692.
104. Pirogovsky, E., Gilbert, P.E., Jacobson, M., et al. Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease. J Clin Exp Neuropsychol 29 (2007), 395–404.
105. Pirogovsky, E., Nicoll, D.R., Challener, D.M., et al. The Visual Spatial Learning Test: differential impairment during the premanifest and manifest stages of Huntington's disease. J Neuropsychol 9 (2015), 77–86.
106. Reedeker, N., Van Der Mast, R.C., Giltay, E.J., Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning. Mov Disord 25:11 (2010), 1612–1618.
107. Reedeker, N., Bouwens, J.A., van Duijn, E., et al. Incidence, course, and predictors of apathy in Huntington's disease: a two-year prospective study. J Neuropsychiatry Clin Neurosci 23 (2011), 434–441.
108. Reedeker, W., van der Mast, R.C., Giltay, E.J., et al. Psychiatric disorders in Huntington's disease: a 2-year follow-up study. Psychosomatics 53 (2012), 220–229.
109. Reilmann, R., Leavitt, B.R., Ross, C.A., Diagnostic criteria for Huntington's disease based on natural history. Mov Disord 29 (2014), 1335–1341.
110. Rickards, H., De Souza, J., Crooks, J., et al. Discriminant analysis of Beck Depression Inventory and Hamilton Rating Scale for Depression in Huntington's disease. J Neuropsychiatry Clin Neurosci 23 (2011), 399–402.
111. Rickards, H., De Souza, J., van Walsem, M., et al. Factor analysis of behavioural symptoms in Huntington's disease. J Neurol Neurosurg Psychiatry 82 (2011), 411–412.
112. Robins Wahlin, T.B., To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington's disease. Patient Educ Couns 65 (2007), 279–287.
113. Robins Wahlin, T.B., Lundin, A., Dear, K., Early cognitive deficits in Swedish gene carriers of Huntington's disease. Neuropsychology 21 (2007), 31–44.
114. Ross, C.A., Pantelyat, A., Kogan, J., et al. Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction. Mov Disord 29 (2014), 1351–1358.
115. Rowe, K.C., Paulsen, J.S., Langbehn, D.R., et al. Self-paced timing detects and tracks change in prodromal Huntington disease. Neuropsychology 24 (2010), 435–442.
116. Rowe, K.C., Paulsen, J.S., Langbehn, D.R., et al. Patterns of serotonergic antidepressant usage in prodromal Huntington disease. Psychiatry Res 196 (2012), 309–314.
117. Scahill, R.I., Hobbs, N.Z., Say, M.J., et al. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy. Hum Brain Mapp 34 (2013), 519–529.
118. Schroll, H., Beste, C., Hamker, F.H., Combined lesions of direct and indirect basal ganglia pathways but not changes in dopamine levels explain learning deficits in patients with Huntington's disease. Eur J Neurosci 41 (2015), 1227–1244.
119. Seyfried, L.S., Kales, H.C., Ignacio, R.V., et al. Predictors of suicide in patients with dementia. Alzheimers Dement 7 (2011), 567–573.
120. Smith, M.M., Mills, J.A., Epping, E.A., et al. Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease. Neuropsychology 26 (2012), 664–669.
121. Snowden, J.S., Austin, N.A., Sembi, S., et al. Emotion recognition in Huntington's disease and frontotemporal dementia. Neuropsychologia 46 (2008), 2638–2649.
122. Solomon, A.C., Stout, J.C., Johnson, S.A., et al. Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia 45 (2007), 1767–1776.
123. Stewart, W.F.S., Ricci, J.A., Chee, E., et al. Cost of lost productive work time among US workers with depression. Eur J Public Health, 15, 2005, 26.
124. Stout, J.C., Paulsen, J.S., Queller, S., et al. Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25 (2011), 1–14.
125. Tabrizi, S.J., Langbehn, D.R., Leavitt, B.R., et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8 (2009), 791–801.
126. Tabrizi, S.J., Scahill, R.I., Durr, A., et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10 (2011), 31–42.
127. Tabrizi, S.J., Scahill, R.I., Owen, G., et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12 (2013), 637–649.
128. Thompson, J.C., Poliakoff, E., Sollom, A.C., et al. Automaticity and attention in Huntington's disease: when two hands are not better than one. Neuropsychologia 48 (2010), 171–178.
129. Tibben, A., Predictive testing for Huntington's disease. Brain Res Bull 72 (2007), 165–171.
130. Unschuld, P.G., Joel, S.E., Pekar, J.J., et al. Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex. Psychiatry Res 203 (2012), 166–174.
131. Vaccarino, A.L., Sills, T., Anderson, K.E., et al. Assessment of depression, anxiety and apathy in prodromal and early huntington disease. PLoS currents, 3, 2011, RRN1242.
132. van Asselen, M., Almeida, I., Julio, F., et al. Implicit contextual learning in prodromal and early stage Huntington's disease patients. J Int Neuropsychol Soc 18 (2012), 689–696.
133. van der Meer, L., van Duijn, E., Wolterbeek, R., et al. Offspring of a parent with genetic disease: childhood experiences and adult psychological characteristics. Health Psychol 33 (2014), 1445–1453.
134. van Duijn, E., Kingma, E.M., van der Mast, R.C., Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci 19 (2007), 441–448.
135. van Duijn, E., Kingma, E.M., Timman, R., et al. Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative first-degree relatives. J Clin Psychiatry 69 (2008), 1804–1810.
136. van Duijn, E., Reedeker, N., Giltay, E.J., et al. Correlates of apathy in Huntington's disease. J Neuropsychiatry Clin Neurosci 22:3 (2010), 287–294.
137. van Duijn, E., Craufurd, D., Hubers, A.A., et al. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry 85 (2014), 1411–1418.
138. Van Liew, C., Gluhm, S., Goldstein, J., et al. The functional implications of motor, cognitive, psychiatric, and social problem-solving states in Huntington's disease. Psychiatry 76 (2013), 323–335.
139. Vitale, C., Pellecchia, M.T., Grossi, D., et al. Unawareness of dyskinesias in Parkinson's and Huntington's diseases. Neurol Sci 22 (2001), 105–106.
140. Wetzel, H.H., Gehl, C.R., Dellefave-Castillo, L., et al. Suicidal ideation in Huntington disease: the role of comorbidity. Psychiatry Res 188 (2011), 372–376.
141. Williams, J.K., Erwin, C., Juhl, A.R., et al. In their own words: reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND-HD study. Am J Med Genet B Neuropsychiatr Genet 153B (2010), 1150–1159.
142. Witt, S.T., Laird, A.R., Meyerand, M.E., Functional neuroimaging correlates of finger-tapping task variations: an ALE meta-analysis. Neuroimage 42 (2008), 343–356.
143. Wolf, R.C., Gron, G., Sambataro, F., et al. Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness. Hum Brain Mapp 33 (2012), 2161–2173.
144. World Health Organization, Depression. Available online at: http://www.who.int/mediacentre/factsheets/fs369/en/, 2015 (accessed February 27 2016).
145. You, S.C., Geschwind, M.D., Sha, S.J., et al. Executive functions in premanifest Huntington's disease. Mov Disord 29 (2014), 405–409.
146. Zakzanis, K.K., The subcortical dementia of Huntington's disease. J Clin Exp Neuropsychol 20 (1998), 565–578.
147. Zhang, Y., Long, J.D., Mills, J.A., et al. Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet 156B (2011), 751–763.
148. Zimbelman, J.L., Paulsen, J.S., Mikos, A., et al. fMRI detection of early neural dysfunction in preclinical Huntington's disease. J Int Neuropsychol Soc 13 (2007), 758–769.